Gene · 6045
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Setting the clock of neural progenitor cells during mammalian corticogenesis. | Semin Cell Dev Biol | 2023 | 35644876 | PubTator, text mining | PubMed |
| Ligandability of E3 Ligases for Targeted Protein Degradation Applications. | Biochemistry | 2023 | 34473924 | PubTator, text mining | PubMed |
| Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives. | Med Rev (2021) | 2022 | 37724161 | PubTator, text mining | PubMed |
| A comparative assessment of RNF38 and P53 genes expression in the sperm samples obtained from males with normozoospermia and asthenospermia: A case-control study. | Int J Reprod Biomed | 2022 | 36819206 | PubTator, text mining | PubMed |
| Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis. | PNAS Nexus | 2022 | 36714878 | PubTator, text mining | PubMed |
| Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers. | Front Genet | 2022 | 36685853 | PubTator, text mining | PubMed |
| Structural basis for ubiquitylation by HOIL-1. | Front Mol Biosci | 2022 | 36685275 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Numerical Analysis of the Effect of Retaining Ring Structure on the Chemical Mechanical Polishing Abrasive Motion State. | Materials (Basel) | 2022 | 36614398 | PubTator, text mining | PubMed |
| TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor. | Nat Commun | 2022 | 36581624 | PubTator, text mining | PubMed |
| The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution. | Front Cell Dev Biol | 2022 | 36578786 | PubTator, text mining | PubMed |
| MDSN: A Module Detection Method for Identifying High-Order Epistatic Interactions. | Genes (Basel) | 2022 | 36553670 | PubTator, text mining | PubMed |
| Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer. | Biomedicines | 2022 | 36551849 | PubTator, text mining | PubMed |
| RINGs, DUBs and Abnormal Brain Growth-Histone H2A Ubiquitination in Brain Development and Disease. | Epigenomes | 2022 | 36547251 | PubTator, text mining | PubMed |
| Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis. | Discov Oncol | 2022 | 36520265 | PubTator, text mining | PubMed |
| PEAC-seq adopts Prime Editor to detect CRISPR off-target and DNA translocation. | Nat Commun | 2022 | 36509752 | PubTator, text mining | PubMed |
| Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors. | Int J Mol Sci | 2022 | 36499442 | PubTator, text mining | PubMed |
| Choosing the Probe for Single-Molecule Fluorescence Microscopy. | Int J Mol Sci | 2022 | 36499276 | PubTator, text mining | PubMed |
| Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma. | Cancers (Basel) | 2022 | 36497479 | PubTator, text mining | PubMed |
| Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity. | Nat Commun | 2022 | 36481767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6045/papers?page=16